Veerhealth Care Secures New Sample Order Worth 76.40 Lakhs from Leading FMCG Giant
Veerhealth Care Limited, a rapidly growing listed company specializing in Ayurvedic and cosmetic formulation manufacturing, has received a new sample order worth approximately 76.40 lakhs from one of India's prominent FMCG companies for skincare products.The agreement involves the manufacture of these skincare items, which are scheduled to be launched under a specific new MRP structure designed for brand promotion and market expansion. The delivery timeframe for this initial sample order is set at 45 days.
The client is identified as a leading FMCG company operating in both domestic and international markets within the personal and household care segment, and it is part of a 125 year old business group.
Veerhealth Care Limited leverages its expertise to offer products under Ayuveer, aiming for exceptional and safe daily care solutions through Ayurvedic medicines and personal care ranges while focusing on quality and affordability.
Operational Strengths and Market Outlook
The company holds a distinct competitive advantage globally as very few small-cap entities possess USFDA plant clearance. Veerhealth Care Limited also specializes in manufacturing Pure Vegetarian toothpaste.Looking ahead, the company has advanced discussions with one of India's largest hotel amenities suppliers, which operates as an Indo-Canadian joint venture.
The financial prospects for Veerhealth Care demonstrate steady growth trajectory across the next two fiscal years. The company is expecting significant advancements in its shareholder value following recent preferential warrants monies receipt.
Key operational and financial data provided by the company includes:
| Metric | FY 2026-27 Expectation | FY 2027-28 Expectation |
|---|---|---|
| Total Income | Approximately 105 crores | Approximately 156 crores |
| PAT (Profit After Tax) | Minimum 5 to 6 crores | Minimum 9 to 10 crores |
| Book Value per Share (FY26) | 1.46 | N/A |
Stock Price Movement
Veerhealth Care Ltd settled at ₹41.50 on Thursday, edging up by 0.97% in post-market trading. The shares traded within a tight intraday band, ranging from a low of ₹40.50 to an intraday high of ₹41.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.